JPMorgan Says Selling Stocks Now Carries Too Much Risk

image

(Bloomberg) — In the face of an increasingly chaotic geopolitical environment, equity investors should avoid panic selling and focus on the market fundamentals, according to JPMorgan Chase & Co.’s head of global equity strategy Mislav Matejka.

“If one is selling on the back of the latest geopolitical developments now, the risk is of getting whipsawed,” Matejka and his team wrote in a note to clients on Monday. “Historically, vast majority of military conflicts, especially if localized, did not tend to hurt investor confidence for too long, and would end up as buying opportunities.”

READ: Portfolios Need Adjustments With Oil Above $100: Taking Stock

The appeal for calm comes as a fresh wave of Western sanctions against Russia and an increasingly aggressive rhetoric by president Vladimir Putin, who ordered his nuclear forces to be on alert over the weekend, exacerbated this year’s rout in equity markets on both sides of the Atlantic.

Banking stocks were the biggest decliners in Europe on Monday, sinking to the lowest in two months, after the U.S. and EU ramped up their measures against Russia blocking some of the nations banks from the international SWIFT transaction messaging system and moving to target the central bank’s foreign exchange reserves.

“We acknowledge that our longs in Europe and in banks are not likely to perform as long as this crisis dominates the headlines,” JPMorgan’s strategists said. Still, on anything longer than a one-month horizon, banks and Europe should continue to be seen as fundamental overweights, the strategists added, “especially if commodity flows are not cut from Russia.”

UBS Global Wealth Management echoed the sentiment on Monday. “We caution against hasty shifts in positioning based on events,” strategists led by Mark Haefele wrote. “We think it is important that investors maintain a calm stance and keep a long-term perspective,” they said, advising investors to diversify across regions, sectors, and asset classes, use commodities as a geopolitical hedge, and position for U.S. dollar strength.

©2022 Bloomberg L.P.

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More